- Home
- KC vs ICUI Comparison
KC vs ICUI Comparison
Compare KC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KC | ICUI |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | China | United States |
| Employees | 13868 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.9B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | KC | ICUI |
|---|---|---|
| Price | $13.88 | $126.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $18.00 | ★ $182.25 |
| AVG Volume (30 Days) | ★ 1.5M | 231.9K |
| Earning Date | 03-25-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $2,231,262,000.00 |
| Revenue This Year | $20.62 | N/A |
| Revenue Next Year | $17.55 | $4.46 |
| P/E Ratio | ★ N/A | $4,306.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.29 | $107.02 |
| 52 Week High | $17.79 | $160.29 |
Technical Indicators
Market Signals| Indicator | KC | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 52.20 | 41.48 |
| Support Level | $12.98 | $122.17 |
| Resistance Level | $15.20 | $135.68 |
| Average True Range (ATR) | 0.67 | 4.57 |
| MACD | -0.04 | 0.53 |
| Stochastic Oscillator | 42.16 | 40.48 |
Price Performance
Historical ComparisonAbout KC Kingsoft Cloud Holdings Limited
Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.